文献
J-GLOBAL ID:201702282455464195
整理番号:17A2002474
天然H sp90阻害剤,パナキシノールは肺癌幹細胞と非幹細胞の両方を標的とする【Powered by NICT】
Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells
著者 (15件):
Le Huong Thuy
(Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Le Huong Thuy
(College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Nguyen Huy Truong
(College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Min Hye-Young
(Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Min Hye-Young
(Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Hyun Seung Yeob
(Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Hyun Seung Yeob
(College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Kwon Soonbum
(College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Lee Yeongcheol
(College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Le Thi Hong Van
(Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam)
,
Lee Jeeyeon
(College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Park Jeong Hill
(College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Lee Ho-Young
(Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Lee Ho-Young
(College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
,
Lee Ho-Young
(Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea)
資料名:
Cancer Letters
(Cancer Letters)
巻:
412
ページ:
297-307
発行年:
2018年
JST資料番号:
E0606B
ISSN:
0304-3835
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)